RCWM
ABBV icon

Royal Capital Wealth Management’s AbbVie ABBV Stock Holding History

Royal Capital Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
8,842
+11
+0.1% +$2.37K 1.25% 20
2026
Q1 		$1.92M Sell
8,831
-811
-8% -$180K 1.2% 22
2025
Q4 		$2.2M Buy
9,642
+6
+0.1% +$1.37K 1.3% 20
2025
Q3 		$2.23M Buy
9,636
+1
+0% +$204 1.37% 19
2025
Q2 		$1.79M Buy
9,635
+13
+0.1% +$2.42K 1.19% 22
2025
Q1 		$2.02M Buy
9,622
+12
+0.1% +$2.33K 1.41% 21
2024
Q4 		$1.71M Sell
9,610
-407
-4% -$74.8K 1.2% 21
2024
Q3 		$1.98M Sell
10,017
-153
-2% -$28.6K 1.4% 19
2024
Q2 		$1.74M Sell
10,170
-84
-0.8% -$13.9K 1.31% 20
2024
Q1 		$1.87M Sell
10,254
-65
-0.6% -$11.2K 1.47% 19
2023
Q4 		$1.6M Sell
10,319
-62
-0.6% -$9.04K 1.38% 19
2023
Q3 		$1.55M Sell
10,381
-138
-1% -$20.3K 1.48% 20
2023
Q2 		$1.42M Sell
10,519
-137
-1% -$20.1K 1.34% 22
2023
Q1 		$1.7M Sell
10,656
-76
-0.7% -$11.6K 1.71% 16
2022
Q4 		$1.73M Buy
10,732
+7
+0.1% +$1.07K 1.84% 15
2022
Q3 		$1.44M Buy
10,725
+179
+2% +$25.7K 1.68% 20
2022
Q2 		$1.61M Buy
10,546
+11
+0.1% +$1.68K 1.75% 18
2022
Q1 		$1.71M Buy
10,535
+300
+3% +$43.6K 1.67% 19
2021
Q4 		$1.39M Buy
+10,235
New +$1.21M 1.34% 21

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Royal Capital Wealth Management's ABBV Position: Q2 2026 in Review

Royal Capital Wealth Management increased its AbbVie (ABBV) stake by 0.12% in Q2 2026, buying an estimated $2.37K and bringing the position to 8,842 shares worth $2.23M. The position accounts for 1.25% of the portfolio, ranked #20.

Royal Capital Wealth Management first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.23M in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Royal Capital Wealth Management held 8,842 shares of AbbVie worth $2.23M as of Q2 2026.
  • Royal Capital Wealth Management bought 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 1.25% of Royal Capital Wealth Management's portfolio in Q2 2026, its #20 holding.
  • Royal Capital Wealth Management first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
  • Royal Capital Wealth Management's AbbVie position peaked at $2.23M in Q3 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Royal Capital Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.